Spotify
Google Podcasts
Apple Podcasts
Breaker
Overcast
Pocket Casts
Radio Public
Anchor
Arrowhead Research Corporation Stock Price (Quote) NASDAQ:ARWR
$34.20 ( 2.61% ) Friday, 27th May 2022
| Range | Low Price | High Price | Comment |
|---|---|---|---|
| 30 days | $27.87 | $44.60 | Friday, 27th May 2022 ARWR stock ended at $34.20. This is 2.61% more than the trading day before Thursday, 26th May 2022. During the day the stock fluctuated 5.38% from a day low at $32.50 to a day high of $34.25. |
| 90 days | $27.87 | $51.11 | |
| 52 weeks | $27.87 | $93.66 |
Historical Arrowhead Research Corporation prices
| Date | Open | High | Low | Close | Volume |
| 2022-05-27 | $33.57 | $34.25 | $32.50 | $34.20 | 753 705 |
| 2022-05-26 | $33.38 | $34.84 | $33.32 | $33.33 | 768 019 |
| 2022-05-25 | $33.52 | $34.27 | $32.78 | $33.97 | 529 510 |
| 2022-05-24 | $35.29 | $35.51 | $33.48 | $33.80 | 782 868 |
| 2022-05-23 | $36.45 | $36.88 | $35.49 | $36.05 | 577 703 |
| 2022-05-20 | $36.01 | $36.64 | $33.90 | $36.21 | 735 591 |
| 2022-05-19 | $34.07 | $35.80 | $33.80 | $35.15 | 881 052 |
| 2022-05-18 | $35.08 | $36.14 | $34.08 | $34.20 | 1 328 134 |
| 2022-05-17 | $33.97 | $35.77 | $33.58 | $35.77 | 1 236 177 |
| 2022-05-16 | $31.52 | $34.19 | $31.00 | $32.88 | 1 136 882 |
| 2022-05-13 | $31.03 | $33.21 | $30.74 | $31.64 | 1 288 085 |
| 2022-05-12 | $28.45 | $31.28 | $27.87 | $30.31 | 1 502 057 |
| 2022-05-11 | $35.30 | $35.50 | $28.53 | $28.95 | 1 973 778 |
| 2022-05-10 | $34.72 | $35.47 | $33.36 | $34.29 | 1 433 980 |
| 2022-05-09 | $35.82 | $36.52 | $32.24 | $32.72 | 1 615 213 |
| 2022-05-06 | $39.39 | $39.49 | $36.48 | $36.92 | 1 094 831 |
| 2022-05-05 | $42.59 | $42.69 | $39.14 | $40.24 | 704 166 |
| 2022-05-04 | $42.99 | $43.23 | $40.11 | $43.01 | 817 820 |
| 2022-05-03 | $42.91 | $44.60 | $41.99 | $42.65 | 583 276 |
| 2022-05-02 | $41.09 | $43.13 | $40.76 | $43.05 | 711 388 |
| 2022-04-29 | $42.07 | $43.43 | $40.83 | $41.11 | 553 235 |
| 2022-04-28 | $42.23 | $42.59 | $39.66 | $42.31 | 552 785 |
| 2022-04-27 | $40.98 | $42.47 | $40.40 | $41.61 | 847 485 |
| 2022-04-26 | $43.18 | $43.89 | $40.88 | $40.91 | 841 908 |
| 2022-04-25 | $42.31 | $44.04 | $42.08 | $43.91 | 449 978 |
| 2022-04-22 | $46.49 | $47.20 | $42.23 | $42.66 | 291 981 |
| 2022-04-21 | $46.49 | $47.20 | $42.50 | $42.74 | 609 500 |
| 2022-04-20 | $46.00 | $46.20 | $44.37 | $45.76 | 531 300 |
| 2022-04-19 | $44.44 | $46.10 | $43.93 | $45.49 | 502 000 |
| 2022-04-18 | $46.67 | $46.67 | $43.95 | $44.33 | 758 400 |
| 2022-04-14 | $48.89 | $49.29 | $46.78 | $46.89 | 409 605 |
| 2022-04-13 | $46.99 | $49.50 | $46.60 | $49.24 | 940 218 |
| 2022-04-12 | $47.54 | $48.73 | $46.08 | $46.86 | 575 958 |
| 2022-04-11 | $47.50 | $48.50 | $46.27 | $46.77 | 440 738 |
| 2022-04-08 | $49.14 | $50.01 | $48.20 | $48.25 | 627 000 |
| 2022-04-07 | $47.89 | $49.41 | $47.86 | $49.01 | 633 500 |
| 2022-04-06 | $47.49 | $49.00 | $46.84 | $48.14 | 601 300 |
| 2022-04-05 | $50.48 | $51.11 | $48.15 | $48.40 | 729 500 |
| 2022-04-04 | $49.22 | $50.77 | $48.42 | $50.61 | 710 900 |
| 2022-04-01 | $46.16 | $50.42 | $46.16 | $49.21 | 848 901 |
| 2022-03-31 | $45.80 | $47.10 | $45.80 | $45.99 | 624 400 |
| 2022-03-30 | $46.41 | $48.31 | $45.34 | $45.59 | 579 806 |
| 2022-03-29 | $45.67 | $46.96 | $45.49 | $46.72 | 650 300 |
| 2022-03-28 | $44.26 | $46.27 | $42.90 | $44.78 | 569 500 |
| 2022-03-25 | $45.36 | $45.88 | $43.44 | $44.11 | 1 246 200 |
| 2022-03-24 | $45.99 | $47.13 | $45.60 | $47.11 | 849 500 |
| 2022-03-23 | $47.37 | $47.53 | $45.43 | $45.58 | 528 400 |
| 2022-03-22 | $45.95 | $48.02 | $45.37 | $47.53 | 679 598 |
| 2022-03-21 | $46.81 | $46.88 | $45.00 | $45.40 | 437 063 |
| 2022-03-18 | $47.00 | $48.76 | $46.87 | $47.38 | 1 989 499 |
Arrowhead Pharmaceuticals, Inc., a biopharmaceutical company, develops novel drugs to treat intractable diseases in the United States. The company utilizes its proprietary Dynamic Polyconjugate platform to develop targeted drugs based on the RNA interference mechanism that silences disease-causing genes. Its ARC-520, an RNAi-based therapeutic that is in Phase IIb clinical efficacy studies to treat chronic hepatitis B virus infection; and ARC-AAT,... Golden Star Signal
This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.
This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!
![StockInvest.us]()
Stock Podcast
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
